Nexira Acquires Tournay Biotechnologies

SOMERVILLE, N.J.Nexira acquired Tournay Biotechnologies a European-based company that specializes in the extraction of active botanicals for the nutraceutical and dietary supplements industriesand plans to expand its offerings and growth to its health business, which is expected to represent 35 percent of its total sales.

2013 saw a real expansion of our production capacities of plant extracts, and with U.S. consumers taking the industry to a whole new level, we are positioned to grow our health business in 2014," said Mathieu Dondain, Nexira director of business development and a fourth generation executive."Whether taken to aid in weight management, stress relief, muscle performance, energy or just overall health, natural botanical extracts will continue to grow in popularity."

Nexira is finishing 2013 with fiscal year sales of more than $130 million, and a projects target growth of more than $170 million by 2015. The company is looking to grow in the United States as new projects continue to develop. Industry studies value vitamin supplements and minerals at $23 billion, and this includes herbal dietary supplement sales which are valued at $5.6 billion, and were up 5.5 percent in 2012 alone, marking the ninth straight year of sales growth.

In addition to the increase in production capabilities, Nexira raised its communication levels through growth at its U.S. headquarters in Somerville, N.J., a tripling of sales staff in the U.S., and the establishment of a new presence on the west coast.